Literature DB >> 23158775

Health-related quality of life in Russian adults with epilepsy: the effect of socio-demographic and clinical factors.

Elina Melikyan1, Alla Guekht, Larisa Milchakova, Anna Lebedeva, Irina Bondareva, Eugeny Gusev.   

Abstract

OBJECTIVE: The aim of this study was to evaluate socio-demographic and clinical factors influencing the health-related quality of life (HRQOL) of adult patients with epilepsy in a naturalistic treatment setting in Russia.
METHODS: The QOLIE-31 questionnaire and the Beck Depression Inventory (BDI) were completed by 208 patients with a broad clinical spectrum of epilepsy (the mean age was 31.49±13.20 years and ranged from 18 to 74 years).
RESULTS: In Russian adult patients with epilepsy, lower mean QOLIE-31 scores were obtained compared with previously published international data for overall HRQOL, emotional well-being, and cognitive functioning and social functioning subscales (p<0.001). Univariate analysis revealed that duration of epilepsy negatively correlated with all QOLIE-31 subscores (p<0.05), except for emotional well-being (p=0.1). In multivariate regression analysis, BDI depression score was the predictor of overall score and all QOLIE-31 domains, except for emotional well-being. Age could be considered as a predictor of cognitive and social functioning, medical effects, and the total QOLIE -31 score. Seizure frequency was a factor associated with all HRQOL domains, except for medication effects and emotional well-being, whereas gender, education, family status, seizure type, employment, lateralization of epileptic foci, number of antiepileptic drugs, and the reported adverse events did not significantly affect HRQOL.
CONCLUSION: The present study has revealed that longer duration of epilepsy, older age, higher seizure frequency, and depression are the potential predictors of worse HRQOL in adult Russian patients with epilepsy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23158775     DOI: 10.1016/j.yebeh.2012.09.042

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  8 in total

1.  Validity and Reliability of the Quality of Life in Epilepsy Inventory (QOLIE-31) for Turkey.

Authors:  Mukadder Mollaoğlu; Zehra Durna; Ertuğrul Bolayir
Journal:  Noro Psikiyatr Ars       Date:  2015-07-07       Impact factor: 1.339

2.  Validity and Reliability of the Quality of Life in Epilepsy Inventory (QOLIE-10) For Turkey.

Authors:  Mukadder Mollaoğlu; Muratcan Mollaoğlu; Zehra Durna
Journal:  Noro Psikiyatr Ars       Date:  2017-01-12       Impact factor: 1.339

3.  What are the predictors of quality of life of people with epilepsy?

Authors:  Dana Brabcova; Jiri Kohout
Journal:  J Neurosci Rural Pract       Date:  2013-08

4.  Comparison of the health-related quality of life between epileptic patients with partial and generalized seizure.

Authors:  Nahid Ashjazadeh; Golnaz Yadollahikhales; Anaheed Ayoobzadehshirazi; Nazanin Sadraii; Negin Hadi
Journal:  Iran J Neurol       Date:  2014-04-03

5.  Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study.

Authors:  Nikolay N Yahno; Anastasia V Fedotova
Journal:  Neuropsychiatr Dis Treat       Date:  2017-11-02       Impact factor: 2.570

6.  Medication-Related Quality of Life in Thai Epilepsy Patients.

Authors:  Phantipa Sakthong; Bavornpat Suriyapakorn
Journal:  J Epilepsy Res       Date:  2019-12-31

7.  Psychiatric comorbidity and quality of life in patients with epilepsy on anti-epileptic monotherapy and polytherapy.

Authors:  Jagriti Yadav; Priti Singh; Surekha Dabla; Rajiv Gupta
Journal:  Tzu Chi Med J       Date:  2021-07-23

8.  Health-related quality of life and its predictors among people living with epilepsy at Dessie Referral Hospital, Amhara, Ethiopia: A cross-sectional study.

Authors:  Alebachew Sisay Stotaw; Prem Kumar; Dessale Abate Beyene; Tamrat Assefa Tadesse; Alfoalem Araba Abiye
Journal:  SAGE Open Med       Date:  2022-10-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.